{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:48:33Z","timestamp":1790689713645,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bbamcr.2025.120058","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T23:26:49Z","timestamp":1757114809000},"page":"120058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["GJB2 promotes ovarian cancer progression and cisplatin resistance by upregulating TNC expression"],"prefix":"10.1016","volume":"1872","author":[{"given":"Jiaxuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Sai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2025.120058_bb0005","article-title":"Treatment of epithelial ovarian cancer","volume":"371","author":"Kuroki","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.bbamcr.2025.120058_bb0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.critrevonc.2019.08.002","article-title":"Hopes and failures in front-line ovarian cancer therapy","volume":"143","author":"Tsibulak","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0015","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ygyno.2014.02.038","article-title":"\u201cPlatinum resistant\u201d ovarian cancer: what is it, who to treat and how to measure benefit?","volume":"133","author":"Davis","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0020","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/carcin\/17.6.1199","article-title":"Role of connexin genes in growth control","volume":"17","author":"Yamasaki","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbamcr.2025.120058_bb0025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jmoldx.2023.07.005","article-title":"Genetic factors contribute to the phenotypic variability in GJB2-related hearing impairment","volume":"25","author":"Chiang","year":"2023","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/jcp.2005.029272","article-title":"Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer","volume":"59","author":"Kanczuga-Koda","year":"2006","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-006-9465-8","article-title":"Connexin26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancer","volume":"106","author":"Naoi","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-07-1184","article-title":"Aberrant expression of connexin 26 is associated with lung metastasis of colorectal cancer","volume":"14","author":"Ezumi","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10549-018-05126-3","article-title":"ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness","volume":"175","author":"Liu","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-13-50","article-title":"The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer","volume":"13","author":"Teleki","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbamcr.2025.120058_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.907960","article-title":"The prognostic value and biological significance of gap junction beta protein 2 (GJB2 or Cx26) in cervical cancer","volume":"12","author":"Meng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.197","article-title":"Reciprocal positive regulation between Cx26 and PI3K\/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT","volume":"6","author":"Yang","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-019-0497-x","article-title":"Emerging roles of gap junction proteins connexins in cancer metastasis, chemoresistance and clinical application","volume":"26","author":"Wu","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088322","article-title":"Epicatechin stimulates mitochondrial activity and selectively sensitizes cancer cells to radiation","volume":"9","author":"Elbaz","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.bbamcr.2025.120058_bb0075","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/jpp\/rgab133","article-title":"Anticancer potential of (\u2212)-epicatechin in a triple-negative mammary gland model","volume":"73","author":"Almaguer","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0080","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1113\/jphysiol.2011.209924","article-title":"(\u2212)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle","volume":"589","author":"Nogueira","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105906","article-title":"(\u2212)-Epicatechin acts as a potent agonist of the membrane androgen receptor, ZIP9 (SLC39A9), to promote apoptosis of breast and prostate cancer cells","volume":"211","author":"Thomas","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28176229","article-title":"(\u2212)-Epicatechin inhibits metastatic-associated proliferation, migration, and invasion of murine breast cancer cells in vitro","volume":"28","author":"P\u00e9rez-Dur\u00e1n","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bbamcr.2025.120058_bb0095","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1158\/1940-6207.CAPR-09-0247","article-title":"New role of (\u2212)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin","volume":"3","author":"Saha","year":"2010","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.bbamcr.2025.120058_bb0100","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1016\/j.fct.2010.09.010","article-title":"Antileukemic action of (\u2212)-epicatechin in the spleen of rats with acute myeloid leukemia","volume":"48","author":"Papiez","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0105","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0110","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114205","article-title":"Therapeutic strategies to overcome cisplatin resistance in ovarian cancer","volume":"232","author":"Song","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0120","article-title":"New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment","volume":"20","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0125","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3892\/or.2014.3163","article-title":"Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT","volume":"31","author":"Yu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0130","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuropharm.2013.05.002","article-title":"Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway","volume":"75","author":"Gielen","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbamcr.2025.120058_bb0135","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s12967-024-05501-3","article-title":"Chlorpromazine overcomes temozolomide resistance in glioblastoma by inhibiting Cx43 and essential DNA repair pathways","volume":"22","author":"Matarrese","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0140","first-page":"2287","article-title":"Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR-Akt pathway","volume":"19","author":"Zhang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0145","article-title":"Extracellular matrix remodeling in the tumor immunity","volume":"14","author":"Du","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0150","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nature04695","article-title":"Lysyl oxidase is essential for hypoxia-induced metastasis","volume":"440","author":"Erler","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2025.120058_bb0155","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809003","article-title":"Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis","volume":"10","author":"Insua-Rodr\u00edguez","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1582-4934.2011.01360.x","article-title":"How do tenascins influence the birth and life of a malignant cell?","volume":"16","author":"Brellier","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0165","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.2174\/0929867330666230404124229","article-title":"Biology of tenascin C and its role in physiology and pathology","volume":"31","author":"Abedsaeidi","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2024.04.002","article-title":"Tenascin-C targeting strategies in cancer","volume":"130","author":"Dhaouadi","year":"2024","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.canlet.2006.02.017","article-title":"Tenascin-C induced signaling in cancer","volume":"244","author":"Orend","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41419-020-2438-8","article-title":"Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C","volume":"11","author":"Steitz","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0185","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/9511","article-title":"Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo","volume":"5","author":"Sethi","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0190","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/nar\/gkv024","article-title":"Global Oct4 target gene analysis reveals novel downstream PTEN and TNC genes required for drug-resistance and metastasis in lung cancer","volume":"43","author":"Tang","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0195","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1158\/1078-0432.CCR-22-0991","article-title":"CircIPO7 promotes nasopharyngeal carcinoma metastasis and cisplatin chemoresistance by facilitating YBX1 nuclear localization","volume":"28","author":"Hong","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2025.120058_bb0200","article-title":"In vivo reversal of P-glycoprotein-mediated drug resistance in a breast cancer xenograft and in leukemia models using a novel, potent, and nontoxic Epicatechin EC31","volume":"24","author":"Sun","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488925001636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488925001636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:26:52Z","timestamp":1759368412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488925001636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0167488925001636"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2025.120058","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GJB2 promotes ovarian cancer progression and cisplatin resistance by upregulating TNC expression","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2025.120058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120058"}}